Fig. 3From: Lipids bearing extruded-spheronized pellets for extended release of poorly soluble antiemetic agent—Meclizine HClFTIR spectra showing (a) pure Meclizine HCl (b) combination of Geleol® and Compritol® in drug/lipid ratio of 1:2 (F17) (c) combination of Geleol® and CW in drug/lipid ratio of 1:2 (F20) (d) combination of Geleol®, Compritol® and CW in drug/lipid ratio of 1:2 (F28)Back to article page